Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 4.4T | 4.6T | 4.9T | 4.1T |
Cost of revenue | 3.5T | 3.6T | 3.9T | 3.2T |
Gross profit | 858.0B | 947.4B | 1.0T | 876.1B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 219.9B | 221.3B | 228.6B | 200.6B |
Other operating expenses | 4.4B | 8.2B | 6.3B | 6.1B |
Operating income | 440.4B | 525.6B | 597.6B | 487.0B |
Non operating interest income | ||||
Income | 5.0B | 6.5B | 3.4B | 2.2B |
Expense | 116.4B | 229.5B | 135.2B | 137.0B |
Other income expense | — | — | — | — |
Pretax income | 457.8B | 272.4B | 533.9B | 313.3B |
Tax provision | 104.4B | 74.1B | 122.5B | 75.0B |
Net income | 353.3B | 198.4B | 411.4B | 238.3B |
Basic EPS | 101.4 | — | — | — |
Diluted EPS | 101.4 | — | — | — |
Basic average shares | 3.5B | — | — | — |
Diluted average shares | 3.5B | — | — | — |
EBITDA | 614.4B | 520.7B | 686.6B | 476.9B |
Net income from continuing op. | — | — | — | — |
Minority interests | — | — | — | 0 |
Preferred stock dividends | 0 | 0 | 0 | 0 |